These findings are consistent with a previous study conducted in AD patients, where it was shown that RCAN1 mRNA was elevated (~ two fold) in the cerebral cortex (areas A10 and A22) and hippocampus, but not the cerebellum, of AD patients [17]. The gene discussed is RCAN1; the disease is Alzheimer disease.